Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain gene: a potential

D F Robinson1, I H Maxwell

  • 1Program in Molecular Biology, University of Colorado Cancer Center, Denver, USA.

Human Gene Therapy
|February 1, 1995
PubMed

Insights

Researchers explored controlling diphtheria toxin A-chain (DT-A) gene expression using genetic mutations. They found that introducing specific mutations and suppressor tRNAs allows precise control over DT-A activity for targeted cell ablation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Targeted gene therapy offers potential for treating diseases like cancer and AIDS.
  • Diphtheria toxin A-chain (DT-A) gene expression can induce specific cell ablation.
  • Modulating DT-A toxicity is crucial for targeting cells with limited regulatory elements.

Purpose of the Study:

  • To investigate the use of nonsense suppression to control DT-A gene expression.
  • To assess the impact of amber mutations on DT-A activity.
  • To evaluate the potential for binary control over targeted tissue ablation.

Main Methods:

  • Introducing amber (TAG) nonsense codons into the DT-A coding sequence.
  • Transfecting HeLa cells with mutated DT-A constructs.
  • Utilizing serine-inserting suppressor tRNA to restore DT-A expression.

Main Results:

  • A single amber mutation significantly reduced DT-A activity.
  • Two amber mutations virtually eliminated DT-A activity.
  • Suppressor tRNA restored DT-A expression in mutated constructs, demonstrating control.

Conclusions:

  • Nonsense suppression provides a mechanism to regulate DT-A expression in mammalian cells.
  • This method enables conditional control over targeted cell ablation.
  • Potential applications include precise cancer and AIDS therapy.